StopUMTS Logo
how to get rid of moles 
Zoeken
   
Voorlichting
22/06/18Stralingsarme babyfoon
21/06/18Aarding en advies elektri
Artikelen
22/06/18SAR waarden, Phones emitt
15/06/18The 25% Revolution—How
07/06/18Bees, Birds and mankind D
07/06/18Is your high blood sugar
04/06/18Verstouwbare waterafstote
31/05/18Fatal collision? Are wire
Berichten Nederland
21/06/18Leeuwarden: straling 5G n
18/06/18‘Nederland wordt digita
15/06/18Duurzaam Antennebeleid We
15/06/1816 juni: Internationale E
09/06/18Buurt in Kerkdriel wil ze
Berichten België
16/06/18Scherpenheuvel-Zichem: Be
14/06/18Tommelein laat straling d
Berichten Internationaal
19/06/18Oostenrijk: Wordt uitzend
07/06/18Oostenrijk: Ärztekammer
04/06/18The roll out of 5G wirele
03/06/18Top mobile phone firms wa
Ervaringen | Appellen/oproepen
28/05/18Stralingsarme werkplek
28/05/18Ervaring in Denemarken
23/05/18Energieverbruik 2 keer zo
Onderzoeken
21/06/18Absorption of wireless ra
17/06/18Metabolic and Genetic Scr
12/06/18The human skin as a sub-T
Veel gestelde vragen
13/05/17Vakantie? Witte zo
10/07/16Zeven veel gestelde vrage
Juridische informatie
01/06/18Wetgeving hoogspanningsli
15/05/18Brit dad sues Nokia for u
02/03/18Formal Complaint to the E
Oproepen
15/06/18Stem voor plan voor een w
24/05/18Lezing in Westerhoven: Sm
25/04/18Workshop: EHS en omgaan m
Folders
10/09/17Brochures, folders, websi
29/04/16USA: Meer dan 50 tips voo
Briefwisselingen | Archief: 2008, 2005
28/05/18Elektromagnetische velden
23/05/18Mail naar Brandpunt over
Illustraties
 Algemeen
 Fotoalbum zendmasten
 Wetenschappelijke illustraties
Changing incidence and improved survival of gliomas    
Ga naar overzicht berichten in: Onderzoeken

Changing incidence and improved survival of gliomas
woensdag, 23 juli 2014 - Dossier: Algemeen


Bron: www.ejcancer.com/article/S0959-8049(14)00718-7/abstract .
24 juni 2014


Vincent K.Y. Hoemail, Jaap C. Reijneveld, Roelien H. Enting, Henri P. Bienfait, Pierre Robe, Brigitta G. Baumert, Otto Visser, On behalf of the Dutch Society for Neuro-Oncology (LWNO)
Received: January 27, 2014; Received in revised form: May 21, 2014; Accepted: May 21, 2014; Published Online: June 24, 2014

Abstract
Background
Tumours of the central nervous system (CNS) represent a relatively rare but serious health burden. This study provides insight into the incidence and survival patterns of gliomas in the Netherlands diagnosed in adult patients during the time period 1989–2010, with a focus on glioblastoma and low-grade gliomas.

Methods
Data on 21,085 gliomas (excluding grade I tumours) were obtained from the Netherlands Cancer Registry, including tumours of the CNS without pathological confirmation. We calculated the age-standardised incidence rates and the estimated annual percentage change (EAPC) for all glioma subtypes. Crude and relative survival rates were estimated using information on the vital status obtained from the Dutch Municipal Personal Records Database.

Results
Incidence of gliomas in adults increased over time, from 4.9 per 100,000 in 1989 to 5.9 in 2010 (EAPC 0.7%, p < 0.001). Two thirds were astrocytoma, 10% oligodendroglioma/oligoastrocytoma, 3% ependymoma and 21% were unspecified. Within the group of astrocytic tumours, the proportion of glioblastoma rose, while the proportion of anaplastic and unspecified astrocytoma decreased. Unspecified neoplasms also decreased, but this was significant only after 2005. Over the course of the study period, glioblastoma patients more often received multimodality treatment with chemotherapy concomitant and adjuvant to radiotherapy. The crude two-year survival rate of glioblastoma patients improved significantly, from 5% in the time period 1989–1994 to 15% in 2006–2010, with median survival increasing from 5.5 to 9 months. The incidence of low-grade gliomas did not change over time. Survival rates for low-grade oligodendroglial and mixed tumours show a modest improvement.

Conclusions
The incidence rate for the total group of gliomas slightly increased, with a decrease of anaplastic and unspecified tumours and an increase of glioblastoma. Following the introduction of combined chemoradiation, two-year survival rates for glioblastoma significantly improved. Survival improved for low-grade gliomas except for low-grade astrocytic tumours.

Keywords:
Glioma, Glioblastoma, Astrocytoma, Oligodendroglioma, Oligoastrocytoma, Ependymoma, Central nervous system, Incidence, Survival


Ga terug naar het hoofdmenu
Afdrukken | Vragen | RSS | Disclaimer